维普中文期刊产品整合服务
55篇 您的检索式:作者名="Smedile"
    题名 作者 年代 出处 被引量
1Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study显示文摘Chiara Giordanino Simone Ceretto Simona Bo Antonina Smedile Alessia Ciancio Elisabetta Bugianesi Rinaldo Pellicano Sharmila Fagoonee Elisabetta Versino Giuseppe Costa Daniele Arese Marco Sacco Mario Rizzetto Giorgio Saracco 2011Digestive and Liver Disease2011,,5:3
2Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014显示文摘AIM To assess the etiology of chronic liver diseases(CLD) from 1998 to 2014 at the outpatient clinic of Gastroenterology of the main hospital in Northwest of Italy among those dedicated to hepatology.METHODS A random sample of charts of patients referred to for increased liver enzymes between January 1998 and December 2006, and between January 2012 and December 2014 were reviewed. Etiology search included testing for hepatitis B virus(HBV), hepatitis C virus(HCV), autoimmune hepatitis, primary biliary cirrhosis, Wilson's disease and hereditary hemocromatosis. A risky alcohol consumption was also considered. Nonalcoholic fatty liver disease(NAFLD) was diagnosed in patients with histological and/or ultrasound evidence of steatosis/steatohepatitis, and without other causes of CLD.RESULTS The number of patients included was 1163. Of them, 528(45%) had positivity for HCV and 85(7%) for HBV. Among the virus-free patients, 417(36%) had metabolic disorders whereas the remaining had history of alcohol abuse, less prevalent causes of CLD or concomitant conditions. In comparison to 1998-2000(41%), a reduction of HCV alone-related cases was detected during the periods 2001-2003(35%, OR = 0.75, 95%CI: 0.53-1.06), 2004-2006(33%, OR = 0.70, 95%CI: 0.50-0.97) and 2012-2014(31%, OR = 0.64, 95%CI: 0.46-0.91). On the contrary, in comparison to 1998-2000(31%), metabolic-alone disorders increased in the period 2004-2006(39%, OR = 1.37, 95%CI: 0.99-1.91) and 2012-2014(41%, OR = 1.53, 95%CI: 1.09-2.16). The other etiologies remained stable. The increase of incidence of metabolic-alone etiology during the period 2004-2006 and 2012-2014 tended to be higher in older patients(≥ 50 years) compared to younger(P = 0.058).CONCLUSION In the Northwest of Italy, during this study period, the prevalence of HCV infection decreased notably whereas that of NAFLD increased.Giorgio Maria Saracco Andrea Evangelista Sharmila Fagoonee Giovannino Ciccone Elisabetta Bugianesi Gian Paolo Caviglia Maria Lorena Abate Mario Rizzetto Rinaldo Pellicano Antonina Smedile 2016World Journal of Gastroenterology2016,22,36:2
3PNPLA 3 rs738409 I748M is associated with steatohepatitis in 434 non‐obese subjects with hepatitis C显示文摘S. Petta E. Vanni E. Bugianesi C. Rosso D. Cabibi C. Cammà V. Di Marco M. Eslam S. Grimaudo F. S. Macaluso D. McLeod R. M. Pipitone M. L. Abate A. Smedile J. George A. Craxì 2015Aliment Pharmacol Ther2015,,10:2
4终末期肝病患者应用G-CSF诱导骨髓源性细胞的可行性与安全性Gaia S. Smedile A. OmedèP. 张红凯 2006世界核心医学期刊文摘(胃肠病学分册)2006,0,11:2
5Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis显示文摘Silvia Gaia Silvia Carenzi Angela L. Barilli Elisabetta Bugianesi Antonina Smedile Franco Brunello Alfredo Marzano Mario Rizzetto 2010Journal of Hepatology2010,,:2
6Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data显示文摘Gioacchino Leandro Alessandra Mangia Jason Hui Paolo Fabris Laura Rubbia–Brandt Guido Colloredo Luigi E. Adinolfi Tarik Asselah Julie R. Jonsson Antonina Smedile Norah Terrault Valerio Pazienza Maria Teresa Giordani Emiliano Giostra Aurelio Sonzogni Giuse 2006Gastroenterology2006,,6:2
7Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen-negative chronic hepatitis B 显示文摘Gaia S Marzano A Smedile A 2004Aliment Pharmacol Ther2004,20,3:1
8Outcome of chronic delta hepatitis in Italy: A long-term cohort study显示文摘Grazia Anna Niro Antonina Smedile Antonio Massimo Ippolito Alessia Ciancio Rosanna Fontana Antonella Olivero Maria Rosa Valvano Maria Lorena Abate Domenica Gioffreda Gian Paolo Caviglia Mario Rizzetto Angelo Andriulli 2010Journal of Hepatology2010,,5:1
9Historlogical changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection显示文摘Rizzetto M Volpes R Smedile A 2000Med Virol2000,61,3:1
10Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease显示文摘Silvia Gaia Antonina Smedile Paola Omedè Antonella Olivero Fiorella Sanavio Federico Balzola Antonio Ottobrelli Maria Lorena Abate Alfredo Marzano Mario Rizzetto Corrado Tarella 2006Journal of Hepatology2006,,1:1
11Hepatitis delta in Europe; vanishing or refreshing? 显示文摘GAETA GB STROFFOLINI T SMEDILE A 2007Hepatology2007,46,:1
12Prophylaxis and treatment of hepatitis B in immunocompromised patients显示文摘A. Marzano E. Angelucci P. Andreone M. Brunetto R. Bruno P. Burra P. Caraceni B. Daniele V. Di Marco F. Fabrizi S. Fagiuoli P. Grossi P. Lampertico R. Meliconi A. Mangia M. Puoti G. Raimondo A. Smedile 2006Digestive and Liver Disease2006,,5:1
13IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy 显示文摘Suppiah V Moldovan M Ahlenstiel G Berg T Weltman M Abate ML Bassendine M Spengler U Dote GJ Powell E Riordan S Sheridan D Smedile A Fragomeli V Muller T Bahlo M Stewart GJ Booth DR George J 2009Nat Genet2009,41,10:1
14Efficacy of amoxicillinplus clavulanic acid -based triple therapy for Helicobacterpylori eradication:A retrospective study 显示文摘Berrutti M Astegiano M Smedile A 2010Pan Minerva Med2010,52,4:1
15Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease显示文摘Gaia s smedile A 0mede P 0,,01:1
16Steatosis and hepatocellular carcinoma risk 显示文摘Smedile A Bugianesi E 2005Eur Rev Med Pharmacol Sci2005,9,5:1
17Feasibility and safety of G- CSF administration to induce bone marrow-derived cells mobiliza- tion in patients with end stage liver disease显示文摘Gala S Smedile A Omede P 2006J Hepatol2006,45,1:1
18Hepatitis delta virus diagnosis显示文摘OLIVERO A SMEDILE A 2012Se- min Liver Dis2012,32,3:1
19IL28Bis associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy显示文摘Suppiah V Moldovan M Ahlenstiel G Berg T Weltman M Abate ML Bassendine M Spengler U Dore GJ Powell E Riordan S Sheridan D Smedile A Fragomeli V Müller T Bahlo M Stewart GJ Booth DR George J 2009Nat Genet2009,41,10:1
20Four years of trement with lamivudine : clinical and vivolog evaluation in HBV antigen-negative chronic hepatitis B 显示文摘Gaia S Mariano A Smedile A 2004Aliment phamacol Ther2004,20,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费